Document:

EXTENSION
AND THIRD AMENDMENT TO LEASE

 

This Extension and Third
Amendment to Lease (the “Amendment”) is made this 30 day of April, 2013, by and between Martens Properties
L.L.L.P., a Maryland limited liability limited partnership (“Landlord”) and Vaccinogen LLC
(“Tenant”).

 

WITNESSETH:

 

WHEREAS,
Landlord and Tenant entered into a certain Lease, dated October 24, 2007, the Extension and First Amendment to Lease dated November
1, 2011 and that certain Second Amendment to Lease dated October 23, 2012, herein collectively referred to as “Lease”,
pursuant to which Tenant leased four thousand and sixty four (4,064) square feet, known as Suite 406 (the “Leased Premises”),
in the commercial office building known as Westview Office Court located at 5300 Westview Drive, Frederick, Maryland 21710 (the
“Building”), and

 

WHEREAS,
the term of the Lease will expire on April 30, 2013, and Landlord and Tenant desire to extend the term of the Lease and amend certain
other terms and conditions hereinafter set forth;

 

NOW THEREFORE,
in consideration of the premises and mutual covenants and agreements contained herein and for other good and valuable consideration,
the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows:

 

1.   Extension
of Lease Term. The term of the Lease is hereby extended for a period of six (6) months, commencing on May 1, 2013 (“Extension
Commencement Date”) and expiring October 31, 2013 (“Lease Expiration Date”). This First Extension Term shall
be upon all the same terms and conditions as set forth in the Lease with respect to the Initial Term thereof, except as modified
herein. Tenant will be provided one (1) additional six (6) month extension period by providing Landlord with sixty days (60) prior
written notice by September 1, 2013 (hereinafter referred to as “Second Extension Period”). In the Second Extension Period
the last three (3) months of the term will be on a month-to-month basis with a termination option available to Tenant, provided
Tenant notifies Landlord in writing of its intent to terminate, sixty (60) days prior to the termination date. Landlord shall have
the right to terminate the lease and any extensions thereof at any time, by providing sixty (60) days prior written notice to Tenant.
All provisions of the Lease shall govern during any extension period.

 

2.   Base
Rent. As of the Extension Commencement Date, the Base Rent amount of Five Thousand Eighty Nine and 38/100 Dollars ($5,089.38)
shall be paid in equal monthly installments.,

 

3.   Additional
Rent. In addition to paying the Base Rent specified in Paragraph 2 above, Tenant shall remain obligated to pay to Landlord
the amounts determined to be Tax Adjustment and Expense Adjustment (collectively called “Additional Rent”) upon the
same terms and conditions as set forth in the Initial Lease.

 

4.   Brokers.
Tenant represents and warrants to Landlord that Tenant has not dealt with any realtor, broker, agent, or finder in connection with
this Amendment other than McShea and Company, Inc. (“Landlord’s Agent”). Tenant shall indemnify and hold Landlord
harmless from and against any loss, claim, damage, expense or liability for any compensation, commission, or charges claimed by
any other realtor, broker, agent, or finder claiming to have dealt with Tenant in connection with this Amendment.

 

5.   Reaffirmation
of Terms. All other terms, covenants, and provisions of the Lease not expressly modified and amended hereby shall remain in
full force and effect, and are hereby ratified and confirmed in all respects.

 

    	Page
                                                                                                                                                                                               1
                                                                                                                                                                                               of
                                                                                                                                                                                               2

    	 

    

 

IN WITNESS WHEREOF, the
parties hereto have duly executed this Extension and Third Amendment to Lease on the day and year first written above.

 

	WITNESS	 	
        TENANT

        VACCINOGEN INC.

	 	 	 
	/s/
    Wilda M. Hankins	 	By:	/s/
Michael G. Hanna, Jr.
	 	 	 
	 	 	Date:	         12April2013

 

	 	 	LANDLORD
	WITNESS	 	MARTENS PROPERTIES L.L.L.P.
	 	 	 
	/s/
Virginia L. Martens	 	By:	/s/ 
	 	 	 
	 	 	Date:	         April 30, 2013SUBSCRIPTION
DOCUMENTS

 

VACCINOGEN,
INC.

 

Offering
of up to 2,370,546 Units 

consisting
of Common Stock and Warrants

 

CONTENTS

 

Instructions for Subscription

 

	Section A:	General Instructions - Wiring and Check Instructions
	 	 
	Section B:	Subscription Agreement
	 	 
	Section C:	Confidential Purchaser Questionnaire

 

    	 

    	 

    

 

SECTION
A

 

INSTRUCTIONS
FOR SUBSCRIPTION FOR UNITS

 

Each
subscriber for Units offered must do the following:

 

		1.	Complete,
                                                              sign and deliver the Subscription Agreement (Section B) included
                                                              in this Subscription Booklet.

 

		2.	Complete,
                                                              sign and deliver the Confidential Purchaser Questionnaire (Section
                                                              C) included in this Subscription Booklet.

 

		3.	Deliver
                                                              payment in the amount of $5.50 per Unit subscribed for in accordance
                                                              with the wire transfer and check instructions as indicated in the
                                                              Subscription Agreement (Section B).

 

		4.	All
                                                              subscriptions from partnerships, corporations, trusts, or limited
                                                              liability companies must be accompanied by resolutions of the appropriate
                                                              corporate authority (board of directors, trustee or managing partners
                                                              or members) and trust documents evidencing the authorization and
                                                              power to make the subscription.

 

			Delivery
                                                            of the completed subscription documents described above and check
                                                            (if applicable) should be delivered directly to the Company at the
                                                            following address:

 

Vaccinogen,
Inc.

5300 Westview
Drive, Suite 406

Frederick, MD
21703

Tel No.: 301-668-8400

Facsimile No.:
301-631-2970

Email: atussing@vaccinogeninc.com

Attention:
Andrew L. Tussing

 

The Company
may accept or reject subscriptions, in whole or in part, in their sole discretion. The offering is available only to “accredited
investors” as defined under Regulation D under the Securities Act of 1933, as amended. In the event a subscription offer
is not accepted by the Company, the subscription funds shall be returned to the subscriber, without interest or deduction thereon.

 

    	A-1

    	 

    

 

SECTION B

 

SUBSCRIPTION
AGREEMENT

 

VACCINOGEN,
INC.

 

Please review,
sign on page B-13 or page B-15, and return to:

 

Vaccinogen,
Inc.

5300 Westview
Drive, Suite 406

Frederick, MD
21703

Tel No.: 301-668-8400

Facsimile No.:
301-631-2970

Email: atussing@vaccinogeninc.com

Attention:
Andrew L. Tussing

 

    	 

    	 

    

 

VACCINOGEN,
INC.

 

SUBSCRIPTION
AGREEMENT

 

The
undersigned (hereinafter “Subscriber”) hereby confirms his/her/its subscription for the purchase of units (“Units”)
of Vaccinogen, Inc., a Maryland corporation (the “Company”), on the terms described below, with each Unit consisting
of:

 

(a)          One
share (the “Shares”) of common stock of the Company, par value $0.0001 per share (the “Common Stock”);

 

(b)          a
warrant (collectively, the “Warrants”) to purchase, at any time prior to the fifth anniversary of the date
of issuance of the Warrant (subject to mandatory exercise), 0.3 shares of Common Stock at the exercise price of $6.05 per whole
share of Common Stock (the “Warrant Exercise Price”). The shares of Common Stock underlying each Warrant are
referred to herein as the “Warrant Shares.”

 

Capitalized
terms used and not otherwise defined herein shall have the meanings set forth for such terms in the Company’s Amended and
Restated Private Placement Memorandum Supplement, dated July __, 2013 (as amended or supplemented, and together with all documents
and exhibits thereto, the “Memorandum”). The Units, the Shares, the Adjustment Shares (as defined in Section
1(d) below), the Warrants and the Warrant Shares are sometimes referred to collectively herein as the “Securities.”

 

In
connection with this subscription, Subscriber and the Company agree as follows:

 

		1.	Purchase and Sale of the
Units; Issuance of Adjustment Shares.

 

(a)          The
Company hereby agrees to issue and to sell to Subscriber, and Subscriber hereby agrees to purchase from the Company, a number
of Units at a price equal to $5.50 per Unit (the “Unit Price”) and for the aggregate subscription amount set
forth on the signature page hereto. The form of Warrant is as annexed to the Memorandum. Upon acceptance of this Subscription
Agreement by the Company, the Company shall issue and deliver to Subscriber a share certificate and a warrant certificate evidencing
the applicable number of Shares and Warrants subscribed for against payment in U.S. Dollars of the Purchase Price (as defined
below).

 

(b)          Subscriber
has hereby delivered and paid concurrently herewith the aggregate purchase price (the “Purchase Price”) set
forth on the signature page hereof required to purchase the Units subscribed for hereunder which amount has been paid in U.S.
Dollars by cash, wire transfer or check, subject to collection, to the order of “Vaccinogen, Inc.”

 

    	B-1

    	 

    

 

(c)          Subscriber
understands and acknowledges that this subscription is part of a proposed placement by the Company of up to 2,370,546 Units, which
offering is being made on a “best efforts” basis (the “Offering”). During the Offering Period,
funds will be held in an account established by the Company and released at the discretion of the Company from time to time. If
a subscription is not accepted, whether in whole or in part, the subscription funds held therein will be returned to the investor
without interest or deduction.

 

(d)          If
the Market Price (as defined below) of the Common Stock on the effective date of the first registration statement on Form S-1
filed by the Company after the date of this Agreement (the “Effectiveness Date Market Price”) is less than
$5.50 per share, then the Company will issue to each Subscriber, for no additional consideration, such number of shares of Common
Stock equal to the difference between (x) the number of Shares that would have been issued to Subscriber if the Unit Price had
been equal to either (1) the Effectiveness Date Market Price or (2) $5.00, whichever is greater and (y) the number of Shares issued
to Subscriber originally issued to purchaser upon the closing of sale of Units to Subscriber pursuant to Section 1(a) above (the
“Adjustment Shares”).

 

“Market
Price,” as of any date, (i) means the average of the last reported sale prices for the shares of Common Stock on the
OTCBB for the five (5) Trading Days immediately preceding such date as reported by Bloomberg, or (ii) if the OTCBB is not the
principal trading market for the shares of Common Stock, the average of the last reported sale prices on the principal trading
market for the Common Stock during the same period as reported by Bloomberg, or (iii) if market value cannot be calculated as
of such date on any of the foregoing bases, the Market Price shall be the fair market value as reasonably determined in good faith
by (a) the Board of Directors of the Company or, at the option of a majority-in-interest of the holders of the outstanding Shares
by (b) an independent investment bank of nationally recognized standing in the valuation of businesses similar to the business
of the corporation. The manner of determining the Market Price of the Common Stock set forth in the foregoing definition shall
apply with respect to any other security in respect of which a determination as to market value must be made hereunder.

 

2.           Covenants,
Representations and Warranties of Subscriber. Subscriber covenants with, and represents and warrants to, the Company as follows:

 

(a)          The
Confidential Purchaser Questionnaire has been completed, signed and delivered to the Company by the Subscriber and is, as of the
date hereof, true, complete, and correct in all respects.

 

(b)          Subscriber
is an “accredited investor” as defined by Rule 501 of Regulation D under the Securities Act of 1933, as amended (the
“Act”), and Subscriber is capable of evaluating the merits and risks of Subscriber’s investment in the
Company and has the capacity to protect Subscriber’s own interests.

 

(c)          Subscriber
acknowledges and understands that the Securities are being purchased for investment purposes and not with a view to distribution
or resale, nor with the intention of selling, transferring or otherwise disposing of all or any part thereof for any particular
price, or at any particular time, or upon the happening of any particular event or circumstances, except selling, transferring,
or disposing of the Securities made in full compliance with all applicable provisions of the Act, the rules and regulations promulgated
by the Securities and Exchange Commission (“SEC”) thereunder, and applicable state securities laws; and that
an investment in the Securities is not a liquid investment.

 

    	B-2

    	 

    

 

(d)          Subscriber
acknowledges the Securities must be held indefinitely unless subsequently registered under the Act or unless an exemption from
such registration is available. Subscriber is aware of the provisions of Rule 144 promulgated under the Act which permit limited
resale of common stock purchased in a private placement subject to the satisfaction of certain conditions, including, among other
things, the existence of a public market for the common stock, the availability of certain current public information about the
Company, the resale occurring not less than one year after a party has purchased and paid for the security to be sold, the sale
being effected through a “broker’s transaction” or in transactions directly with a “market maker”
and the number of shares of common stock being sold during any three-month period not exceeding specified limitations.

 

(e)          Subscriber
acknowledges that Subscriber has had the opportunity to ask questions of, and receive answers from the Company or any person acting
on its behalf concerning the Company and its business and to obtain any additional information, to the extent possessed by the
Company (or to the extent it could have been acquired by the Company without unreasonable effort or expense) necessary to verify
the accuracy of the information received by Subscriber. In connection therewith, Subscriber acknowledges that Subscriber has had
the opportunity to discuss the Company’s business, management and financial affairs with the Company’s management
or any person acting on its behalf. Subscriber has received and reviewed the Memorandum, and all the information, both written
and oral, that it desires. Without limiting the generality of the foregoing, Subscriber has been furnished with or has had the
opportunity to acquire, and to review: (i) copies of all of the Company’s publicly available documents, and (ii) all information,
both written and oral, it desires with respect to the Company’s business, management, financial affairs and prospects. In
determining whether to make this investment, Subscriber has relied solely on Subscriber’s own knowledge and understanding
of the Company and its business based upon Subscriber’s own due diligence investigations and the information furnished pursuant
to this paragraph. Subscriber understands that no person has been authorized to give any information or to make any representations
which were not furnished pursuant to this paragraph and Subscriber has not relied on any other representations or information.

 

(f)          Subscriber
has all requisite legal and other power and authority to execute and deliver this Subscription Agreement and to carry out and
perform Subscriber’s obligations under the terms of this Subscription Agreement. This Subscription Agreement constitutes
a valid and legally binding obligation of Subscriber, enforceable in accordance with its terms, and subject to laws of general
application relating to bankruptcy, insolvency and the relief of debtors and rules of law governing specific performance, injunctive
relief or other general principals of equity, whether such enforcement is considered in a proceeding in equity or law.

 

    	B-3

    	 

    

 

(g)          Subscriber
has carefully considered and has discussed with the Subscriber’s professional legal, tax, accounting and financial advisors,
to the extent Subscriber has deemed necessary, the suitability of this investment and the transactions contemplated by this Subscription
Agreement for the Subscriber’s particular federal, state, local and foreign tax and financial situation and has determined
that this investment and the transactions contemplated by this Subscription Agreement are a suitable investment for the Subscriber.
Subscriber relies solely on such advisors and not on any statements or representations of the Company or any of its agents. Subscriber
understands that Subscriber (and not the Company) shall be responsible for Subscriber’s own tax liabilities which may arise
as a result of this investment or the transactions contemplated by this Subscription Agreement.

 

(h)          Neither
this Subscription Agreement nor the Confidential Purchaser Questionnaire contain any untrue statement of a material fact or omit
any material fact concerning Subscriber.

 

(i)           There
are no actions, suits, proceedings or investigations pending against Subscriber or Subscriber’s properties before any court
or governmental agency (nor, to Subscriber’s knowledge, is there any threat thereof) which would impair in any way Subscriber’s
ability to enter into and fully perform Subscriber’s commitments and obligations under this Subscription Agreement or the
transactions contemplated hereby.

 

(j)          The
execution, delivery and performance of and compliance with this Subscription Agreement and the issuance of the Securities will
not result in any material violation of, or conflict with, or constitute a material default under, any of Subscriber’s articles
of incorporation or bylaws or other governing documents, if applicable, or any of Subscriber’s material agreements nor result
in the creation of any mortgage, pledge, lien, encumbrance or charge against any of the assets or properties of Subscriber or
the Securities.

 

(k)          Subscriber
acknowledges the Securities are speculative and involve a high degree of risk and that Subscriber can bear the economic risk of
the purchase of the Securities, including a total loss of his/her/its investment.

 

(l)          Subscriber
acknowledges he/she/it has carefully reviewed and considered the risk factors discussed in the “Risk Factors” section
of the Memorandum prior to making an investment decision.

 

(m)         Subscriber
recognizes that no federal, state or foreign agency has recommended or endorsed the purchase of the Securities.

 

(n)          Subscriber
is aware the Securities are and will be, when issued, “restricted securities” as that term is defined in Rule 144
of the general rules and regulations under the Act.

 

(o)          Subscriber
understands any and all certificates representing the Securities and any and all securities issued in replacement thereof or in
exchange therefore shall bear the following legend or one substantially similar thereto, which Subscriber has read and understands:

 

    	B-4

    	 

    

 

“THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS
AND NEITHER THE SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD, TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT
PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT OR SUCH LAWS OR AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT AND
SUCH LAWS WHICH, IN THE OPINION OF COUNSEL FOR THIS CORPORATION, IS AVAILABLE.”

 

(p)          Because
of the restrictions imposed on resale, Subscriber understands the Company shall have the right to note stop-transfer instructions
in its stock transfer records, and Subscriber has been informed of the Company’s intention to do so. Any sales, transfers,
or any other dispositions of the Securities by Subscriber, if any, will be in compliance with the Act.

 

(q)          Subscriber
acknowledges that Subscriber has such knowledge and experience in financial and business matters that he/she/it is capable of
evaluating the merits and risks of an investment in the Securities and of making an informed investment decision.

 

(r)          Subscriber
represents: (i) Subscriber is able to bear the economic risks of an investment in the Securities and to afford the complete loss
of the investment, and (ii) (A) Subscriber could be reasonably assumed to have the capacity to protect his/her/its own interests
in connection with this subscription; or (B) Subscriber has a pre-existing personal or business relationship with either the Company
or any affiliate thereof of such duration and nature as would enable a reasonably prudent purchaser to be aware of the character,
business acumen and general business and financial circumstances of the Company or such affiliate and is otherwise personally
qualified to evaluate and assess the risks, nature and other aspects of this subscription.

 

(s)          Subscriber
further represents the address set forth in the Confidential Purchaser Questionnaire is his/her principal residence (or, if Subscriber
is a company, partnership or other entity, the address of its principal place of business); that Subscriber is purchasing the
Securities for Subscriber’s own account and not, in whole or in part, for the account of any other person; Subscriber is
purchasing the Securities for investment and not with a view to resale or distribution; and Subscriber has not formed any entity
for the purpose of purchasing the Securities.

 

(t)          Subscriber
understands the Company shall have the unconditional right to accept or reject each subscription, in whole or in part, for any
reason or without a specific reason, in the sole and absolute discretion of the Company (even after receipt and clearance of Subscriber’s
funds). No subscription will be binding upon the Company until accepted by an authorized officer of the Company. In the event
the subscription is rejected, Subscriber’s subscription funds will be returned without interest thereon or deduction therefrom.

 

(u)          Subscriber
has not been furnished with any oral representation or oral information in connection with the offering of the Securities that
is not contained in the Memorandum and this Subscription Agreement.

 

    	B-5

    	 

    

 

(v)         Subscriber
represents that Subscriber is not subscribing for Securities as a result of or subsequent to any advertisement, article, notice
or other communication published in any newspaper, magazine or similar media or broadcast over the Internet, television or radio
or presented at any seminar or meeting.

 

(w)          Subscriber
represents that Subscriber is not subscribing for Securities as a result of any registration statement filed by the Company with
the Securities and Exchange Commission..

 

(x)          Subscriber
has carefully read this Subscription Agreement, the Warrant, and the Memorandum, and Subscriber has accurately completed the Confidential
Purchaser Questionnaire which accompanies this Subscription Agreement.

 

(y)          No
representations or warranties have been made to Subscriber by the Company, or any officer, employee, agent, affiliate or subsidiary
of the Company, other than the representations of the Company contained herein, and in subscribing for the Securities, Subscriber
is not relying upon any representations other than those contained in the Memorandum or in this Subscription Agreement.

 

(z)          Subscriber
represents and warrants, to the best of its knowledge, that other than set forth in the Memorandum, no finder, broker, agent,
financial advisor or other intermediary, nor any purchaser representative or any broker-dealer acting as a broker, is entitled
to any compensation in connection with the transactions contemplated by this Subscription Agreement.

 

(aa)         Subscriber
represents and warrants that Subscriber: (i) has not distributed or reproduced the Memorandum, in whole or in part, at any time,
without the prior written consent of the Company; and (ii) for three (3) years from the date hereof will keep confidential the
existence of the Memorandum and the information contained therein or made available in connection with any further investigation
of the Company and not use the information about the Company for any other purpose.

 

(bb)         If
Subscriber is a trust, this investment, together with all other securities of the Company held by the trust, does not exceed 10%
of the trust assets.

 

3.           Covenants,
Representations and Warranties of the Company. The Company covenants with, and represents and warrants to, Subscriber as follows:

 

(a)          The
Company is duly organized and validly exists as a corporation in good standing under the laws of the State of Maryland.

 

(b)          The
Company has all such corporate power and authority to enter into, deliver and perform this Subscription Agreement and the Warrant.

 

    	B-6

    	 

    

 

(c)          All
necessary corporate action has been duly and validly taken by the Company to authorize the execution, delivery and performance
of this Subscription Agreement and the Warrant by the Company, and the issuance and sale of the Securities to be sold by the Company
pursuant to this Subscription Agreement and the Warrant. This Subscription Agreement and the Warrant have been duly and validly
authorized, executed and delivered by the Company and constitutes the legal, valid and binding obligation of the Company enforceable
against the Company in accordance with its terms, except as the enforceability thereof may be limited by bankruptcy, insolvency,
reorganization, moratorium or other similar laws affecting the enforcement of creditors’ rights generally and by general
equitable principles.

 

(d)          As
of the date hereof, there is no litigation, arbitration, claim, governmental or other proceeding (formal or informal), or investigation
pending or to the Company's knowledge threatened, with respect to the Company, or its respective operations, businesses, properties,
or assets, except as properly described in the Memorandum or such as individually or in the aggregate do not now have and will
not, to the best knowledge of the Company, in the future have a material adverse effect upon the operations, business, properties
or assets of the Company. The Company is not, nor as of each Closing Date shall be, in violation of, or in default with respect
to, any law, rule, regulation, order, judgment or decree, except as properly described in the Memorandum or such as individually
or in the aggregate do not have and will not in the future have a material adverse effect upon the operations, business, properties,
or assets of the Company; nor is the Company required to take any action in order to avoid any such violation or default.

 

(e)          To
its best knowledge, the Company has not infringed, is not infringing, nor has received notice of any claim that the Company has
infringed with respect to asserted intellectual property rights (including, without limitation, copyright, patent, trademark,
trade dress, service mark and any other intellectual property rights) of others. To the best knowledge of the Company, none of
the patents, patent applications, trademarks, service marks, trade names and copyrights, and licenses and rights to the foregoing
presently owned or held by the Company, materially infringe upon any like right of any other person or entity. The Company: (i)
owns or has the right to use, free and clear of all liens, charges, claims, encumbrances, pledges, security interests, defects
or other restrictions of any kind whatsoever, sufficient patents, trademarks, service marks, trade names, copyrights, licenses
and rights with respect to the foregoing, to conduct its business as presently conducted except as set forth in the Memorandum,
and (ii) except as set forth in the Memorandum, is not obligated or under any liability whatsoever to make any payments by way
of royalties, fees or otherwise to any owner or licensee of, or other claimant to, any patent, trademark, service mark, trade
name, copyright, know-how, technology or other intangible asset, with respect to the use thereof or in connection with the conduct
of its business as now conducted or otherwise. The Company has direct ownership of title to all its intellectual property (including
all United States and foreign patent applications and patents), other proprietary rights, confidential information and know-how.

 

    	B-7

    	 

    

 

(f)          The
Units (and component parts) and the Adjustment Shares to be issued and sold to the undersigned as provided in the Memorandum and
in this Subscription Agreement have been duly authorized and when issued and delivered against payment therefor, will be validly
issued, fully paid and non-assessable and will conform to the description thereof in the Memorandum. The Warrants are exercisable
for Common Stock and the shares of Common Stock issuable upon exercise of the Warrants have been duly authorized and when issued
and delivered upon exercise and due payment therefor will be validly issued, fully paid and non-assessable and will conform to
the description thereof in the Memorandum; and, except as set forth in the Memorandum, there are no preemptive or other rights
to subscribe for or to purchase, nor any restriction upon the voting or transfer of, any shares of Common Stock issuable to Subscriber
(whether issued directly as part of the Units, upon exercise of the Warrants or issuance of the Adjustment Shares) pursuant to
the Company's certificate of incorporation or by-laws or any agreement or other outstanding instrument to which the Company is
a party or is otherwise known to the Company. The Company has reserved sufficient shares of Common Stock to be issued upon exercise
of the Warrants and for issuance of the Adjustment Shares.

 

4.           Indemnification.
Subscriber agrees to indemnify and hold harmless the Company and its officers, directors, employees, shareholders, agents representatives
and affiliates, and any person acting on behalf of the Company, from and against any and all damage, loss, liability, cost and
expense (including reasonable attorneys’ fees) which any of them may incur by reason of the failure by Subscriber to fulfill
any of the terms and conditions of this Subscription Agreement, or by reason of any breach of the representations and warranties
made by Subscriber herein, or in any other document provided by Subscriber to the Company. All representations, warranties and
covenants of each of Subscriber and the Company contained herein shall survive the acceptance of this subscription.

 

5.           Patriot
Act Compliance. (Terms used in this section are defined in paragraph (d) below.)

 

To
induce the Company to accept the undersigned’s investment, the undersigned hereby makes the following representations, warranties
and covenants to the Company:

 

(a)          The
undersigned represents and warrants that no holder of any beneficial interest in the undersigned’s equity securities of
the Company (each a “Beneficial Interest Holder”) and, no Related Person (in the case the undersigned is an
entity) is or will be:

 

		(1)	A person
                                                             or entity whose name appears on the list of specially designated
                                                             nationals and blocked persons maintained by the Office of Foreign
                                                             Asset Control from time to time;

 

		(2)	A Foreign
                                                             Shell Bank; or

 

		(3)	A person
                                                             or entity resident in or whose subscription funds are transferred
                                                             from or through an account in a Non-Cooperative Jurisdiction.

 

(b)          The
undersigned represents that the bank or other financial institution (the “Wiring Institution”) from which the
undersigned’s funds will be wired is located in a FATF Country.

 

    	B-8

    	 

    

 

(c)          The
undersigned represents that:

 

		(1)	Neither
                                                             it, any Beneficial Interest Holder nor any Related Person (in the
                                                             case of the undersigned is an entity) is a Senior Foreign Political
                                                             Figure, any member of a Senior Foreign Political Figure’s Immediate
                                                             Family or any Close Associate of a Senior Foreign Political Figure;

 

		(2)	Neither
                                                             it, any Beneficial Interest Holder nor any Related Person (in the
                                                             case the undersigned is an entity) is resident in, or organized or
                                                             chartered under the laws of, a jurisdiction designated by the Secretary
                                                             of the Treasury under Section 311 or 312 of the USA PATRIOT Act as
                                                             warranting special measures due to money laundering concerns; and

 

		(3)	Its investment
                                                             funds do not originate from, nor will they be routed through, an
                                                             account maintained at a Foreign Shell Bank, an “offshore bank,”
                                                             or a bank organized or chartered under the laws of a Non-Cooperative
                                                             Jurisdiction.

 

(d)          Definitions:

 

Close
Associate: With respect to a Senior Foreign Political Figure, a person who is widely and publicly known internationally to
maintain an unusually close relationship with the Senior Foreign Political Figure, and includes a person who is in a position
to conduct substantial domestic and international financial transactions on behalf of the Senior Foreign Political Figure.

 

FATF:
The Financial Action Task Force on Money Laundering.

 

FATF
Country: A country that is a member of FATF. As of September 1, 2003, the countries which are members of FATF are: Argentina;
Australia; Austria; Belgium; Brazil; Canada; Denmark; Finland; France; Germany; Greece; Hong Kong; Iceland; Ireland; Italy; Japan;
Luxembourg; Mexico; Kingdom of the Netherlands; New Zealand; Norway; Portugal; Singapore; South Africa; Spain; Sweden; Switzerland;
Turkey; United Kingdom and United States. For a current list of FATF members see http://www1.oecd.org/fatf/Members_en.htm.

 

Foreign
Bank: An organization which (i) is organized under the laws of a country outside the United States; (ii) engages in the business
of banking; (iii) is recognized as a bank by the bank supervisory or monetary authority of the country of its organization or
principal banking operations; (iv) receives deposits to a substantial extent in the regular course of its business; and (v) has
the power to accept demand deposits, but does not include the U.S. branches or agencies of a foreign bank.

 

Foreign
Shell Bank: A Foreign Bank without a Physical Presence in any country, but does not include a Regulated Affiliate.

 

Government
Entity: Any government or any state, department or other political subdivision thereof, or any governmental body, agency,
authority or instrumentality in any jurisdiction exercising executive, legislative, regulatory or administrative functions of
or pertaining to government.

 

    	B-9

    	 

    

 

Immediate
Family: With respect to a Senior Foreign Political Figure, typically includes the political figure’s parents, siblings,
spouse, children and in-laws.

 

Non-Cooperative
Jurisdiction: Any foreign country or territory that has been designated as non-cooperative with international anti-money laundering
principles or procedures by an intergovernmental group or organization, such as FATF, of which the United States is a member and
with which designation the United States representative to the group or organization continues to concur. See http://www1.oecd.org/fatf/NCCT_en.htm
for FATF’s list of non-cooperative countries and territories.

 

Physical
Presence: A place of business maintained by a Foreign Bank and is located at a fixed address, other than solely a post office
box or an electronic address, in a country in which the Foreign Bank is authorized to conduct banking activities, at which location
the Foreign Bank: (a) employs one or more individuals on a full-time basis; (b) maintains operating records related to its banking
activities; and (c) is subject to inspection by the banking authority that licensed the Foreign Bank to conduct banking activities.

 

Publicly
Traded Company: An entity whose securities are listed on a recognized securities exchange or quoted on an automated quotation
system in the U.S. or country other than a Non-Cooperative Jurisdiction or a wholly-owned subsidiary of such an entity.

 

Qualified
Plan: A tax qualified pension or retirement plan in which at least 100 employees participate that is maintained by an employer
organized in the U.S. or is a U.S. Government Entity.

 

Regulated
Affiliate: A Foreign Shell Bank that: (a) is an affiliate of a depository institution, credit union or Foreign Bank that maintains
a Physical Presence in the U.S. or a foreign country, as applicable; and (b) is subject to supervision by a banking authority
in the country regulating such affiliated depository institution, credit union or Foreign Bank.

 

Related
Person: With respect to any entity, any interest holder, director, senior officer, trustee, beneficiary or grantor of such
entity; provided that in the case of an entity that is a Publicly Traded Company or a Qualified Plan, the term “Related
Person” shall exclude any interest holder holding less than 5% of any class of securities of such Publicly Traded Company
and beneficiaries of such Qualified Plan.

 

Senior
Foreign Political Figure: A senior official in the executive, legislative, administrative, military or judicial branches of
a non-U.S. government (whether elected or not), a senior official of a major non-U.S. political party, or a senior executive of
a non-U.S. government-owned corporation. In addition, a Senior Foreign Political Figure includes any corporation, business or
other entity that has been formed by, or for the benefit of, a Senior Foreign Political Figure.

 

USA
PATRIOT Act: The Uniting and Strengthening America by Providing Appropriate Tools Required to Intercept and Obstruct Terrorism
(USA PATRIOT Act) Act of 2001 (Pub. L. No. 107-56).

 

    	B-10

    	 

    

 

6.           Independent
Nature of Subscriber’s Obligations and Rights. The obligations of the Subscriber under this Agreement and any other
documents delivered in connection herewith and therewith (collectively, the “Transaction Documents”) are several and
not joint with the obligations of any other purchaser of Units, and the Subscriber is not responsible in any way for the performance
of the obligations of any other purchaser of Units under any Transaction Document. The decision of the Subscriber to purchase
Units pursuant to the Transaction Documents has been made by the Subscriber independently of any other purchaser of Units. Nothing
contained herein or in any Transaction Document, and no action taken by any purchaser of Units pursuant thereto, shall be deemed
to constitute such purchasers as a partnership, an association, a joint venture, or any other kind of entity, or create a presumption
that the purchasers of Units are in any way acting in concert or as a group with respect to such obligations or the transactions
contemplated by the Transaction Documents. The Subscriber acknowledges that no other purchaser of Units has acted as agent for
the Subscriber in connection with making its investment hereunder and that no other purchaser of Units will be acting as agent
of the Subscriber in connection with monitoring its investment in the Units or enforcing its rights under the Transaction Documents.
The Subscriber shall be entitled to independently protect and enforce its rights, including without limitation the rights arising
out of this Agreement or out of the other Transaction Documents, and it shall not be necessary for any other purchaser of Units
to be joined as an additional party in any proceeding for such purpose.

 

7.           Miscellaneous.

 

(a)          Subscriber
agrees not to transfer or assign this Subscription Agreement or any of Subscriber’s interest herein and further agrees that
the transfer or assignment of the Securities acquired pursuant hereto shall be made only in accordance with all applicable laws.

 

(b)          Subscriber
agrees that Subscriber cannot cancel, terminate or revoke this Subscription Agreement or any agreement of Subscriber made hereunder,
and this Subscription Agreement shall survive the death or legal disability of Subscriber and shall be binding upon Subscriber’s
heirs, executors, administrators, successors and permitted assigns.

 

(c)          Subscriber
has read and accurately completed this entire Subscription Agreement and Memorandum.

 

(d)          This
Subscription Agreement constitutes the entire agreement among the parties hereto with respect to the subject matter hereof and
may be amended only by a written execution by all parties.

 

(f)          Subscriber
acknowledges it has been advised to consult with his/her/its own attorney regarding this subscription and Subscriber has done
so to the extent that Subscriber deems appropriate. Subscriber understands and agrees that Subscriber has not been represented
in this transaction by counsel to the Company.

 

    	B-11

    	 

    

 

(g)          Any
notice or other document required or permitted to be given or delivered to the Subscriber shall be in writing and sent: (i) by
registered or certified mail with return receipt requested (postage prepaid) or (ii) by a recognized overnight delivery service
(with charges prepaid).

 

If
to the Company, at:

 

Vaccinogen,
Inc.

5300
Westview Drive, Suite 406

Frederick,
MD 21703

Tel
No.: 301-668-8400

Facsimile
No.: 301-631-2970

Email:
atussing@vaccinogeninc.com

Attention:
Andrew L. Tussing

 

If
to the Subscriber, at its address set forth on the signature page to this Subscription Agreement, or such other address as it
shall have specified to the Company in writing.

 

(h)          Failure
of the Company to exercise any right or remedy under this Subscription Agreement or any other agreement between the Company and
the Subscriber, or otherwise, or delay by the Company in exercising such right or remedy, will not operate as a waiver thereof.
No waiver by the Company will be effective unless and until it is in writing and signed by the Company.

 

(i)          This
Subscription Agreement shall be enforced, governed and construed in all respects in accordance with the laws of the State of Maryland,
as such laws are applied by the Maryland courts except with respect to the conflicts of law provisions thereof, and shall be binding
upon the Subscriber, the Subscriber’s heirs, estate, legal representatives, successors and assigns and shall inure to the
benefit of the Company, its successors and assigns.

 

(j)          Any
legal suit, action or proceeding arising out of or relating to this Subscription Agreement or the transactions contemplated hereby
shall be instituted exclusively in state or federal courts located in County of Frederick, State of Maryland (the “Maryland
Courts”). The parties hereto hereby: (i) waive any objection which they may now have or hereafter have to the venue
of any such suit, action or proceeding, and (ii) irrevocably consent to the jurisdiction of the applicable Maryland Court in any
such suit, action or proceeding. The parties further agree to accept and acknowledge service of any and all process which may
be served in any such suit, action or proceeding in the Maryland Courts and agree that service of process upon a party mailed
by certified mail to such party’s address shall be deemed in every respect effective service of process upon such party
in any such suit, action or proceeding.

 

(k)          If
any provision of this Subscription Agreement is held to be invalid or unenforceable under any applicable statute or rule of law,
then such provision shall be deemed modified to conform to such statute or rule of law. Any provision hereof that may prove invalid
or unenforceable under any law shall not affect the validity or enforceability of any other provisions hereof.

 

    	B-12

    	 

    

 

(l)
         The parties understand and agree money damages would not be a sufficient remedy for any breach of the Subscription Agreement
by the Company or the Subscriber and that the party against which such breach is committed shall be entitled to equitable relief,
including injunction and specific performance, as a remedy for any such breach. Such remedies shall not be deemed to be the exclusive
remedies for a breach by either party of the Subscription Agreement but shall be in addition to all other remedies available at
law or equity to the party against which such breach is committed.

 

(m)          All
pronouns and any variations thereof used herein shall be deemed to refer to the masculine, feminine, singular or plural, as identity
of the person or persons may require.

 

(n)          This
Subscription Agreement may be executed in counterparts and by facsimile, each of which shall be deemed an original, but all of
which shall constitute one and the same instrument.

 

[Signature Pages
Follow]

 

    	B-13

    	 

    

 

Signature
Page for Individuals:

 

IN
WITNESS WHEREOF, Subscriber has caused this Subscription Agreement to be executed as of the date indicated below.

 

	$______________________($5.50 per Unit)	 	 
	Purchase Price	 	Number of Units
	 	 	 
	 	 	 
	Print or Type Name	 	Print or Type Name (Joint-owner)
	 	 	 
	 	 	 
	Signature	 	Signature (Joint-owner)
	 	 	 
	 	 	 
	Date	 	Date (Joint-owner)
	 	 	 
	 	 	 
	IRS Taxpayer Identification Number	 	IRS Taxpayer Identification Number (Joint-owner)
	 	 	 
	 	 	 
	Address	 	Address (Joint-owner)
	 	 	 
	Telephone Number	 	Telephone Number
	 	 	 
	Fax Number	 	Fax Number
	 	 	 
	E-mail Address	 	E-mail Address

 

Type of Ownership

 

		 ̈	Individual

		 ̈	Tenants in common

		 ̈	Joint tenants with right of
survivorship

		 ̈	Community property (check
only if resident of community property state)

		 ̈	Other (please specify:____________________)

 

    	B-14

    	 

    

 

Wiring Instructions:

 

	Bank Name:	 	M&T Bank
	ABA #:	 	022000046
	Tel Number:	 	301 698 7825
	Address:	 	26 North Ct. Street, Frederick, MD 21701
	Acct #:	 	984 555 6001
	Swift Code:	 	MANTUS33
	Acct. Name:	 	Vaccinogen, Inc.
	Reference:	 	Vaccinogen Investment

 

    	B-15

    	 

    

 

Partnerships,
Corporations or Other Entities:

 

IN
WITNESS WHEREOF, Subscriber has caused this Subscription Agreement to be executed as of the date indicated below.

 

	$ ______________________($5.50 per Unit)	 	_____________________________
	Total Purchase Price	 	Number of Units

 

	 
	Print or Type Name of Entity
	 
	Address

 

______________________________

Telephone Number

 

______________________________

Fax Number

 

______________________________

Email Address

 

	 	 	 
	Taxpayer I.D. No. (if applicable)	 	Date
	 	 	 
	By: ____________________________________	 	 
	Signature: Name:	 	Print or Type Name and Indicate
	Title:	 	Title or Position with Entity
	 	 	 
	 	 	 
	Signature (other authorized signatory)	 	Print or Type Name and Indicate
	 	 	Title or Position with Entity

 

Type of Ownership

 

		 ̈	Individual

		 ̈	Tenants in common

		 ̈	Joint tenants with right of
survivorship

		 ̈	Community property (check
only if resident of community property state)

		 ̈	Other (please specify:____________________)

 

    	B-16

    	 

    

 

All subscriptions
from partnerships, corporations, trusts or limited liability companies must be accompanied by resolutions of the appropriate corporate
authority (board of directors, trustee or managing partner or members, as applicable) and trust documents evidencing the authorization
and power to make the subscription.

 

Wiring Instructions:

 

	Bank Name:	 	M&T Bank
	ABA #:	 	022000046
	Tel Number:	 	301 698 7825
	Address:	 	26 North Ct. Street, Frederick, MD 21701
	Acct #:	 	984 555 6001
	Acct. Name:	 	MANTUS33
	Reference:	 	Vaccinogen, Inc.

 

    	B-17

    	 

    

 

SUBSCRIPTION
ACCEPTANCE BY VACCINOGEN, INC.

 

IN
WITNESS WHEREOF, the Company has caused this Subscription Agreement to be executed, and the foregoing subscription accepted, as
of the date indicated below.

 

	 	Vaccinogen, Inc.
	 	 	 
	 	By:	__________________________________
	 	 	Name: _____________________________
	 	 	Title: _______________________________

 

Date: _______________________,
2013

 

    	B-18

    	 

    

 

SECTION
C

 

CONFIDENTIAL
PURCHASER QUESTIONNAIRE

 

Please review,
sign on page C-8, and return to:

 

Vaccinogen,
Inc.

5300 Westview
Drive, Suite 406

Frederick, MD
21703

Tel No.: 301-668-8400

Facsimile No.:
301-631-2970

Email: atussing@vaccinogeninc.com

Attention:
Andrew L. Tussing

 

    	 

    	 

    

 

CONFIDENTIAL
PURCHASER QUESTIONNAIRE

 

THIS QUESTIONNAIRE
WILL BE USED IN CONNECTION WITH THE UNDERSIGNED’S EXPRESSED INTEREST IN A PROPOSED INVESTMENT IN VACCINOGEN, INC. (THE “COMPANY”).

 

THE COMPANY
SHALL HAVE THE RIGHT TO FULLY RELY ON THE REPRESENTATIONS AND WARRANTIES CONTAINED HEREIN UNTIL SUCH TIME AS THE UNDERSIGNED HAS
FURNISHED AN AMENDED CONFIDENTIAL PURCHASER QUESTIONNAIRE.

 

THIS QUESTIONNAIRE
MUST BE ANSWERED FULLY AND RETURNED TO THE COMPANY

 

THE INFORMATION
SUPPLIED IN THIS QUESTIONNAIRE WILL BE HELD IN STRICT CONFIDENCE. NO INFORMATION WILL BE DISCLOSED EXCEPT TO THE EXTENT THAT SUCH
DISCLOSURE IS REQUIRED BY LAW OR REGULATION, OTHERWISE DEMANDED BY PROPER LEGAL PROCESS OR IN LITIGATION INVOLVING THE COMPANY
AND ITS CONTROLLING PERSONS.

 

(1)         The
undersigned represents and warrants that he, she or it comes within at least one category marked below, and that for any category
marked, he, she or it has truthfully set forth, where applicable, the factual basis or reason the undersigned comes within that
category. The undersigned agrees to furnish any additional information which any issuer of securities deems necessary in order
to verify the answers set forth below.

 

	Category A ___	The undersigned is an individual (not a partnership,
    corporation, etc.) whose individual net worth, or joint net worth with his or her spouse, presently exceeds $1,000,000.
	 	 
	 	Explanation. In calculating net worth you may include equity in
    personal property and real estate (excluding your principal residence), cash, short-term investments, stock and securities.  Equity
    in personal property and real estate should be based on the fair market value of such property less debt secured by such property.
	 	 
	Category B ___	The undersigned is an individual (not a partnership, corporation,
    etc.) who had an income in excess of $200,000 in each of the two most recent years, or joint income with his or her spouse
    in excess of $300,000 in each of those years (in each case including foreign income, tax exempt income and full amount of
    capital gains and losses but excluding any income of other family members and any unrealized capital appreciation) and has
    a reasonable expectation of reaching the same income level in the current year.

 

    	C-1

    	 

    

 

	Category C ___	The undersigned is a director or executive officer
    of the company which is issuing and selling the Securities.
	 	 
	Category D ___	The undersigned is (i) a bank, as defined in Section 3(a)(2) of
    the Securities Act of 1933, as amended (the “Act”); (ii) a savings and loan association or other institution as
    defined in Section 3(a)(5)(A) of the Act, whether acting in its individual or fiduciary capacity; (iii) an insurance company
    as defined in Section 2(13) of the Act; (iv) an investment company registered under the Investment Company Act of 1940 or
    a business development company as defined in Section 2(a)(48) of that Act; (v) a Small Business Investment Company (SBIC)
    licensed by the U.S. Small Business Administration under Section 301(c) or (d) of the Small Business Investment Act of 1958;
    or (vi) a plan established and maintained by a state, its political subdivisions, or any agency or instrumentality of a state
    or its political subdivisions, for the benefit of its employees, if such plan has total assets in excess of $5,000,000;

 

	 	 
	 	 

 

	Category E ___	The undersigned is an (i) employee benefit plan within
    the meaning of the Employee Retirement Income Security Act of 1974 if the investment decision is made by a plan fiduciary,
    as defined in Section 3(21) of such act, which is either a bank, savings and loan association, insurance company, or registered
    investment advisor, (ii) an employee benefit plan with total assets in excess of $5,000,000, or (iii) a self-directed employee
    benefit plan (including a self-directed individual retirement account or IRA, Keough or SEP plan) with investment decisions
    made solely by persons that are accredited investors (describe entity).

 

	 	 
	 	 

 

	Category F ___	The undersigned is a private business development company
    as defined in section 202(a) (22) of the Investment Advisors Act of 1940 (describe entity)  

 

	 	 
	 	 

 

	Category G ___	The undersigned is either a corporation, limited liability
    company, partnership, Massachusetts business trust, or non-profit organization within the meaning of Section 501(c)(3) of
    the Internal Revenue Code, in each case not formed for the specific purpose of acquiring the Securities and with total assets
    in excess of $5,000,000. (describe entity)

 

	 	 
	 	 

 

    	C-2

    	 

    

 

	Category H ___	The undersigned is a trust with total assets in excess
    of $5,000,000, not formed for the specific purpose of acquiring the Securities, where the purchase is directed by a “sophisticated
    investor” as defined in Regulation  506(b)(2)(ii) under the Act. (Must also answer Question 5 below).
	 	 
	Category I ___	The undersigned is an entity (other than a trust) in which all
    of the equity owners are “accredited investors” within one or more of the above categories.  If relying
    upon this category alone, each equity owner must complete a separate copy of this Purchaser Questionnaire.  (describe
    entity below)

 

	 	 
	 	 

 

The
undersigned agrees that the undersigned will notify the Company at any time in the event that the representations and warranties
in this Purchaser Questionnaire shall cease to be true, accurate and complete.

 

		(2)	Suitability (please answer
each question)

 

		(a)	For an
                                                             individual, please describe your current employment, including the
                                                             company by which you are employed and its principal business:

 

	 	 
	 	 
	 	 

 

		(b)	For an
                                                             individual, please describe any college or graduate degrees held
                                                             by you:

 

	 	 
	 	 
	 	 

 

		(c)	For all subscribers, please
list types of prior investments:

 

	 	 
	 	 
	 	 

 

		(d)	For all
                                                             subscribers, please state whether you have participated in other
                                                             private placements before:

 

	YES	 	 	NO	 

 

    	C-3

    	 

    

 

		(e)	If your
                                                             answer to question (d) above was “YES”, please indicate
                                                             frequency of such prior participation in private placements
                                                             of:

 

	 	 	Public

Companies	 	Private

Companies
	Frequently	 	 	 	 
	Occasionally	 	 	 	 
	Never	 	 	 	 

 

		(f)	For individuals,
                                                             do you expect your current level of income to significantly decrease
                                                             in the foreseeable future?

 

	YES	 	 	NO	 

 

		(g)	For trust,
                                                             corporate, partnership and other institutional subscribers, do you
                                                             expect your total assets to significantly decrease in the foreseeable
                                                             future?

 

	YES	 	 	NO	 

 

		(h)	For all
                                                             subscribers, do you have any other investments or contingent liabilities
                                                             which you reasonably anticipate could cause you to need sudden cash
                                                             requirements in excess of cash readily available to you?

 

	YES	 	 	NO	 

 

		(i)	For all
                                                             subscribers, are you familiar with the risk aspects and the non-liquidity
                                                             of investments such as the Securities for which you seek to purchase?

 

	YES	 	 	NO	 

 

		(j)	For all
                                                             subscribers, do you understand that there is no guarantee of financial
                                                             return on this investment and that you run the risk of losing your
                                                             entire investment?

 

	YES	 	 	NO	 

 

    	C-4

    	 

    

 

(3)        Provide
the name (and affiliation) of the person responsible for soliciting your interest in the proposed investment in the Company:

 

______________________________________________________________________________________:

 

(4)        Manner
in which title is to be held: (circle one)

 

		(a)	Individual Ownership

		(b)	Community Property

		(c)	Joint Tenant with Right of
Survivorship (both parties must sign)

		(d)	Partnership

		(e)	Tenants in Common

		(f)	Limited Liability Company

		(g)	Corporation

		(h)	Trust

		(i)	Other

 

(5)        NASD
Affiliation.

 

Are
you affiliated or associated with an NASD member firm (please check one):

 

	YES	 	 	NO	 

 

If
Yes, please describe:

 

_________________________________________________________

_________________________________________________________

_________________________________________________________

 

*If
subscriber is a Registered Representative with an NASD member firm, have the following acknowledgment signed by the appropriate
party:

 

The
undersigned NASD member firm acknowledges receipt of the notice required by the NASD Conduct Rules.

 

_________________________________

Name
of NASD Member Firm

 

By:
______________________________

Authorized
Officer

 

Date:
____________________________

 

    	C-5

    	 

    

 

(6)
For Trust Subscribers

 

A.
Certain trusts generally may not qualify as accredited investors except under special circumstances. Therefore, if you intend
to hold securities in whole or in part through a trust, please answer each of the following questions.

 

Is
the trustee of the trust a national or state bank that is acting in its fiduciary capacity in making the investment on behalf
of the trust?

 

	Yes o	No o

 

B.
If the trust is a revocable trust, please complete Question 1 below. If the trust is an irrevocable trust, please
complete Question 2 below.

 

		1.	REVOCABLE TRUSTS

 

Can
the trust be amended or revoked at any time by its grantors:

 

	Yes o	No o

 

If
yes, please answer the following questions relating to each grantor (please add sheets if necessary):

 

Grantor
Name: _________________________

 

Net
worth of grantor (including spouse, if applicable), including home, home furnishings and automobiles exceeds $1,000,000?

 

	Yes o	No o

 

OR

 

Income
(exclusive of any income attributable to spouse) was in excess of $200,000 for the prior two taxable years and is reasonably expected
to be in excess of $200,000 for the current taxable year?

 

	Yes o	No o

 

OR

 

Income
(including income attributable to spouse) was in excess of $300,000 for the prior two taxable years and is reasonably expected
to be in excess of $300,000 for the current taxable year?

 

	Yes o	No o

 

    	C-6

    	 

    

 

		2.	IRREVOCABLE TRUSTS

 

If
the trust is an irrevocable trust, please answer the following questions:

 

Please
provide the name of each trustee:

 

Trustee
Name: ________________________________________

 

Trustee
Name: ________________________________________

 

Does
the trust have assets greater than $5 million?

 

	Yes  ̈	No  ̈

 

Indicate
how often you invest in:

 

Marketable
Securities

 

	Often o	Occasionally o	Seldom o	Never o

 

Restricted
Securities

 

	Often o	Occasionally o	Seldom o	Never o

 

Venture
Capital Companies

 

	Often o	Occasionally o	Seldom o	Never o

 

This
completes the questions applicable to Trust Investors. Please sign below.

 

    	C-7

    	 

    

 

The
undersigned has been informed of the significance of the foregoing representations and answers contained in this Confidential
Purchaser Questionnaire and such representations and answers have been provided with the understanding that the Company, will
rely on them.

 

	 	 	Individual
	 	 	 
	Date:  ________________________	 	 
	 	 	Name of Individual
	 	 	(Please type or print)
	 	 	 
	 	 	 
	 	 	Signature of Individual
	 	 	 
	 	 	 
	 	 	Name of Joint Owner
	 	 	(Please type or print)
	 	 	 
	 	 	 
	 	 	Signature (Joint Owner)
	 	 	 
	 	 	Partnership, Corporation or
	 	 	Other Entity
	 	 	 
	Date:  ________________________	 	 
	 	 	Print or Type Entity Name
	 	 	 
	 	By:	_______________________
	 	 	Name:
	 	 	Title:
	 	 	 
	 	 	 
	 	 	Signature (other authorized signatory, if any)

 

    	C-8

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00219-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00219-of-00352.parquet"}]]